Recombinant CD19 (Tafasitamab Biosimilar) anticorps (Biotin)

N° du produit ABIN7828992

Cet anticorps anti-CD19 (Tafasitamab Biosimilar) Monoclonal Humanized conjugué à Biotin (ABIN7828992) détecte spécifiquement CD19 (Tafasitamab Biosimilar). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant CD19 (Tafasitamab Biosimilar) anticorps (Biotin) (ABIN7828992)

Antigène: CD19 (Tafasitamab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Monoclonal

Conjugué: Cet anticorp CD19 (Tafasitamab Biosimilar) est conjugé à/à la Biotin

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-CD19 (Tafasitamab Biosimilar) anticorps (Biotin)

Fonction: Biotinylated Anti-CD19(tafasitamab biosimilar) mAb

Isotype: IgG1, IgG2, kappa

Information d'application

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur CD19 (Tafasitamab Biosimilar)

Antigène: CD19 (Tafasitamab Biosimilar)

Autre désignation: Tafasitamab Biosimilar

Classe de substances: Biosimilar

Sujet: Synonyms Target:CD19,B4,CVID3,MGC12802
Synonyms Antibody:ICP-B04,ICP B04,MOR 208,MOR208,MOR-208,XENP-5574,XENP5574,XENP 5574,XmAb-5574,XmAb5574,XmAb 5574

UniProt: P15391